Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

KARIS BIO USA, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

KARIS BIO USA, INC.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: Q6LUFER5MEM3

Founded: —Source: [GOV]
Headquarters: ATLANTA, GeorgiaSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

KARIS BIO USA, INC. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $306,607 in 2025. These are non-dilutive federal research grants, not equity financing. The company is based in ATLANTA, Georgia.

Funding rounds

1 rounds

STTR Phase I award (HHS)GrantSep 2025Source: [GOV]
$306.6K
—post-money

Investors

No investors recorded yet for KARIS BIO USA, INC..

Add an investor

People

Leadership

YOUNGSUP YOONPrincipal investigatorSince 2025Source: [GOV]

Acquisitions

KARIS BIO USA, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for KARIS BIO USA, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.